Achiko AG: Achiko's Joint Venture Partner Obtains A Distribution Certificate for Aptamex, A Novel Diagnostic Test for Covid-19 In Indonesia, And Commences Product Registration

Share:
Achiko AG's joint venture partner PT Indonesia Farma Medis (IFM) obtains medical device distribution certificate
Achiko subsequently commenced product registration with its partners with a view to mid-year commercial product availability
Achiko to generate revenues on a 50% holding of the joint venture and a 10% licensing fee from gross sales
ZURICH, SWITZERLAND / ACCESSWIRE / April 29, 2021 /Achiko AG's (SWX:ACHI, ISIN CH0522213468) joint venture partner PT Indonesia Farma Medis ("IFM") has been granted a medical device distribution certificate for Indonesia and commences product registration for AptameX.
This certificate will allow for the procurement, storage and distribution of the novel diagnostic test, AptameX (formerly Project Gumnuts) in Indonesia. It establishes the foundation for a subsequent product registration facilitating the production and sales of the product in Indonesia. Achiko has subsequently commenced product registration with its partners with a view to a mid-year commercial product availability.

Related Keywords

Indonesia ,Germany ,Seoul ,Soult Ukpyolsi ,South Korea ,Hong Kong ,Singapore ,Zurich ,Züsz ,Switzerland ,Austria ,Jakarta ,Jakarta Raya ,Indonesian ,Marcus Balogh ,Farma Medis ,Farner Consulting Ltd ,Project Gumnuts ,Medika Indonesia ,Teman Sehat ,இந்தோனேசியா ,ஜெர்மனி ,சியோல் ,தெற்கு கொரியா ,ஹாங் காங் ,சிங்கப்பூர் ,ஸுரி ,சுவிட்சர்லாந்து ,ஆஸ்ட்ரியா ,ஜகார்த்தா ,ஜகார்த்தா ராய ,இந்தோனேசிய ,மார்கஸ் பலோக் ,விவசாயி ஆலோசனை லிமிடெட் ,மேதிக்க இந்தோனேசியா ,தேமன் சேஹத் ,